A detailed history of Azimuth Capital Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Azimuth Capital Investment Management LLC holds 21,444 shares of VRTX stock, worth $8.52 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
21,444
Previous 21,549 0.49%
Holding current value
$8.52 Million
Previous $10.1 Million 1.26%
% of portfolio
0.4%
Previous 0.42%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$460.0 - $505.78 $48,300 - $53,106
-105 Reduced 0.49%
21,444 $9.97 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $29,460 - $36,414
-75 Reduced 0.35%
21,549 $10.1 Million
Q1 2024

May 14, 2024

SELL
$407.69 - $446.08 $8.33 Million - $9.11 Million
-20,421 Reduced 48.57%
21,624 $9.04 Million
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $171,500 - $205,340
-500 Reduced 1.18%
42,045 $17.1 Million
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $197,497 - $211,676
-584 Reduced 1.35%
42,545 $14.8 Million
Q2 2023

Aug 14, 2023

SELL
$314.42 - $351.91 $239,588 - $268,155
-762 Reduced 1.74%
43,129 $15.2 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $30,588 - $34,894
108 Added 0.25%
43,891 $13.8 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $2.39 Million - $2.69 Million
8,353 Added 23.58%
43,783 $12.6 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $40,253 - $44,912
-147 Reduced 0.41%
35,430 $10.3 Million
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $8.36 Million - $10.4 Million
35,577 New
35,577 $10 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $102B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Azimuth Capital Investment Management LLC Portfolio

Follow Azimuth Capital Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azimuth Capital Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Azimuth Capital Investment Management LLC with notifications on news.